Incentivise hospitals, attract MNCs to boost biologic drug trials in India: Experts

Thiruvananthapuram, Oct 9 (UNI) Incentivising hospitals and healthcare professionals and attracting multinational companies (MNCs) to conduct clinical trials in India are crucial to scaling up biologic drug development and manufacturing, experts said at Bio Connect 4.0 here on Friday. Addressing a session on 'Next-Gen Biologics: From Discovery to Market', experts highlighted the decline in clinical trials in India in recent years and stressed the need to strengthen the country's clinical research ecosystem, improve global acceptance of trial data and promote industry-academia collaboration. Murali Neelakanthan, Principal Lawyer at Amicus, emphasised the need to incentivise hospitals, doctors, technicians and nurses to encourage…